These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20127427)

  • 1. Effect of formulation parameters on the preparation of superporous hydrogel self-nanoemulsifying drug delivery system (SNEDDS) of carvedilol.
    Mahmoud EA; Bendas ER; Mohamed MI
    AAPS PharmSciTech; 2010 Mar; 11(1):221-5. PubMed ID: 20127427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and evaluation of self-nanoemulsifying tablets of carvedilol.
    Mahmoud EA; Bendas ER; Mohamed MI
    AAPS PharmSciTech; 2009; 10(1):183-92. PubMed ID: 19238556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential.
    Singh B; Khurana L; Bandyopadhyay S; Kapil R; Katare OO
    Drug Deliv; 2011 Nov; 18(8):599-612. PubMed ID: 22008038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of novel interpenetrating network gellan gum-poly(vinyl alcohol) hydrogel microspheres for the controlled release of carvedilol.
    Agnihotri SA; Aminabhavi TM
    Drug Dev Ind Pharm; 2005 Jul; 31(6):491-503. PubMed ID: 16109622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Floating microspheres of carvedilol as gastro retentive drug delivery system: 3(2) full factorial design and in vitro evaluation.
    Nila MV; Sudhir MR; Cinu TA; Aleykutty NA; Jose S
    Drug Deliv; 2014 Mar; 21(2):110-7. PubMed ID: 24028280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized nanoemulsifying systems with enhanced bioavailability of carvedilol.
    Singh B; Singh R; Bandyopadhyay S; Kapil R; Garg B
    Colloids Surf B Biointerfaces; 2013 Jan; 101():465-74. PubMed ID: 23010056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Soluplus/Poloxamer 407-based self-nanoemulsifying drug delivery system for the weakly basic drug carvedilol to improve its bioavailability.
    Han H; Li Y; Peng Z; Long K; Zheng C; Wang W; Webster TJ; Ge L
    Nanomedicine; 2020 Jul; 27():102199. PubMed ID: 32275957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development, Optimization, and Evaluation of Carvedilol-Loaded Solid Lipid Nanoparticles for Intranasal Drug Delivery.
    Aboud HM; El Komy MH; Ali AA; El Menshawe SF; Abd Elbary A
    AAPS PharmSciTech; 2016 Dec; 17(6):1353-1365. PubMed ID: 26743643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug.
    Mohsin K; Alamri R; Ahmad A; Raish M; Alanazi FK; Hussain MD
    Int J Nanomedicine; 2016; 11():2829-38. PubMed ID: 27366063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro-ex vivo correlations between a cell-laden hydrogel and mucosal tissue for screening composite delivery systems.
    Blakney AK; Little AB; Jiang Y; Woodrow KA
    Drug Deliv; 2016 Nov; 24(1):582-590. PubMed ID: 28222612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and in vivo evaluation of carvedilol buccal mucoadhesive patches.
    Thimmasetty J; Pandey G; Babu P
    Pak J Pharm Sci; 2008 Jul; 21(3):241-8. PubMed ID: 18614419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical modeling, optimization and characterization of solid self-nanoemulsifying drug delivery system of lopinavir using design of experiment.
    Patel G; Shelat P; Lalwani A
    Drug Deliv; 2016 Oct; 23(8):3027-3042. PubMed ID: 26882014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and evaluation of SEDDS and SMEDDS containing carvedilol.
    Wei L; Sun P; Nie S; Pan W
    Drug Dev Ind Pharm; 2005 Sep; 31(8):785-94. PubMed ID: 16221613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface-adsorbed reverse micelle-loaded solid self-nanoemulsifying drug delivery system of talinolol.
    Shakeel F; Haq N; Alanazi FK; Alsarra IA
    Pharm Dev Technol; 2016 Mar; 21(2):131-9. PubMed ID: 25318634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical vaginal drug delivery system based on superporous hydrogel hybrids.
    Chavda H; Chavada G; Patel J; Rangpadiya K; Patel C
    Protein Pept Lett; 2014; 21(11):1176-84. PubMed ID: 25106910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of bioadhesive chitosan superporous hydrogel composite particles based intestinal drug delivery system.
    Chavda H; Modhia I; Mehta A; Patel R; Patel C
    Biomed Res Int; 2013; 2013():563651. PubMed ID: 23984380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of different physicochemical characteristics and supersaturation principle of solidified SNEDDS and surface-modified microspheres on the bioavailability of carvedilol.
    Choi JE; Kim JS; Choi MJ; Baek K; Woo MR; Kim JO; Choi HG; Jin SG
    Int J Pharm; 2021 Mar; 597():120377. PubMed ID: 33581270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of oral bioavailability of E804 by self-nanoemulsifying drug delivery system (SNEDDS) in rats.
    Heshmati N; Cheng X; Eisenbrand G; Fricker G
    J Pharm Sci; 2013 Oct; 102(10):3792-9. PubMed ID: 23934779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation by design of felodipine loaded liquid and solid self nanoemulsifying drug delivery systems using Box-Behnken design.
    Verma S; Singh SK; Verma PR; Ahsan MN
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1358-70. PubMed ID: 23879216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid self-nanoemulsifying drug delivery systems for oral delivery of polypeptide-k: Formulation, optimization, in-vitro and in-vivo antidiabetic evaluation.
    Garg V; Kaur P; Singh SK; Kumar B; Bawa P; Gulati M; Yadav AK
    Eur J Pharm Sci; 2017 Nov; 109():297-315. PubMed ID: 28842349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.